Inari Medical Inc. (NARI)
NASDAQ (NGS) NASDAQ (NGS) Primary 
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Inari Medical, Inc.(NARI) Shareholders
NEW YORK, NY / ACCESSWIRE / June 4, 2024 / If you suffered a loss on your Inari Medical, Inc. (NASDAQ:NARI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
NARI IMPORTANT SHAREHOLDER UPDATE: The Schall Law Firm Encourages Investors in Inari Medical, Inc. with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / June 4, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Inari Medical, Inc. ("Inari" or "the Company") (NASDAQ:NARI) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 24, 2022 and February 28, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before July 12, 2024.
Inari's (NARI) Expanding Product Portfolio Offsets Competition
Inari's (NARI) VTE products are driving its top line on the back of robust adoption. The company is expanding in additional indications to fuel growth and fight competition.
July 12, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against NARI
NEW YORK, NY / ACCESSWIRE / June 4, 2024 / If you suffered a loss on your Inari Medical, Inc. (NASDAQ:NARI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
NARI LAWSUIT ALERT: Levi & Korsinsky Notifies Inari Medical, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK, NY / ACCESSWIRE / June 3, 2024 / If you suffered a loss on your Inari Medical, Inc. (NASDAQ:NARI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
INARI MEDICAL SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Inari Medical, Inc. - NARI
NEW ORLEANS, LA / ACCESSWIRE / June 3, 2024 / Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until July 12, 2024 to file lead plaintiff applications in a securities class action lawsuit against Inari Medical, Inc. (Nasdaq:NARI), if they purchased the Company's shares between February 24, 2022 and February 28, 2024, inclusive (the "Class Period").
Investors who lost money on Inari Medical, Inc.(NARI) should contact Levi & Korsinsky about pending Class Action - NARI
NEW YORK, NY / ACCESSWIRE / June 3, 2024 / If you suffered a loss on your Inari Medical, Inc. (NASDAQ:NARI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
July 12, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against NARI
NEW YORK, NY / ACCESSWIRE / June 3, 2024 / If you suffered a loss on your Inari Medical, Inc. (NASDAQ:NARI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
Levi & Korsinsky Reminds Inari Medical Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 12, 2024 - NARI
NEW YORK, NY / ACCESSWIRE / June 3, 2024 / If you suffered a loss on your Inari Medical, Inc. (NASDAQ:NARI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
NARI ONGOING INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Inari Medical, Inc. with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / June 3, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Inari Medical, Inc. ("Inari" or "the Company") (NASDAQ:NARI) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 24, 2022 and February 28, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before July 12, 2024.
NARI LAWSUIT ALERT: Levi & Korsinsky Notifies Inari Medical, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK, NY / ACCESSWIRE / June 3, 2024 / If you suffered a loss on your Inari Medical, Inc. (NASDAQ:NARI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
Shareholders of Inari Medical, Inc. Should Contact Levi & Korsinsky Before July 12, 2024 to Discuss Your Rights – NARI
NEW YORK, NY / ACCESSWIRE / June 3, 2024 / If you suffered a loss on your Inari Medical, Inc. (NASDAQ:NARI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
